Alvotech

ALVO.IC·Iceland·Healthcare
Compare
584.00+22.00 (+3.91%)today
At close: Nov 6, 3:29 PM GMT · May be delayed up to 15 min · ISK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close562.00
Open554.00
Day range552.00584.00
52-week range364.00800.00
Off day high0.00%
Off 52-week high−27.00%
Volume150.28K
Avg. volume (3M)159.60K
Market cap208.38B
EPS (TTM)-77.75
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.24
Shares outstanding356.82M
Short interest—
Earnings dateNov 11, 2026
Analyst target—
Profit margin−36.31%

Against its peers

Compare in full ›
ALVO.IC MOREPENLAB.NS GLENMARK.NS SOLARA.NS B6E.F ALKS
Market cap 208.38B 50.55B 730.96B 30.58B 15.26B 7.71B
P/E (TTM) — 26.9 50.4 82.2 25.4 —
Forward P/E — — 26.7 20.2 — 33.9
Price/book -1,087.5 3.7 6.5 2.1 0.4 4.1
Dividend yield — 0.21% 0.20% — — —
1-year change −19.71% +106.73% +37.00% +13.85% +49.26% +35.42%
Today +3.91% −4.99% +4.36% −1.49% −1.13% +3.05%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All ALVO.IC news ›
Eyes On Eyecare·Positive

Alcon acquires Neurotech, MacTel therapy Encelto

Alcon, Inc. has purchased Neurotech Pharmaceuticals, Inc., developer of the first and only FDA-approved treatment for Macular Telangiectasia Type 2 (MacTel). Alcon shared two details surrounding the transaction: Headquartered in…

Stock Titan·Positive

Alvotech: SIMLANDI output per batch more than doubles

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania Fort Technology: Logia USA Signs Exclusive Distribution Agreement to Expand Fuel Maintenance Solutions for Data…

MarketScreener··2 outlets

Alvotech And Advanz Pharma Holdco Limited Submit European Regulatory Application For AVT29, Proposed Biosimilar To Eylea 8 Mg

Alvotech and Advanz Pharma announced the submission of a European regulatory application for AVT29, a proposed biosimilar to Eylea® 8 mg , which is marketed as Eylea HD® in the United States. Based... Alvotech and Advanz Pharma announced…

LLY
More from 1 other outlet

From the 4Search news index, newest first.

In the news

61mentions in 30 days
52with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 61 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance